Comparison between Genxai Analytics IPO and Vahh Chemicals IPO.
Genxai Analytics IPO is a SME Fixed Price IPO proposed to list at NSE SME while Vahh Chemicals IPO is a SME Fixed Price proposed to list at BSE SME.
The total issue size of Genxai Analytics IPO is up to ₹0.00 Cr whereas the issue size of the Vahh Chemicals IPO is up to ₹11.28 Cr. The final issue price of Genxai Analytics IPO is and of Vahh Chemicals IPO is ₹53.00 per share.
| Genxai Analytics IPO | Vahh Chemicals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹53.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | |
| Fresh Issue Size | 50,04,000 shares | 21,28,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹11.28 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 50,04,000 shares | 21,28,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹11.28 Cr |
Genxai Analytics IPO opens on , while Vahh Chemicals IPO opens on . The closing date of Genxai Analytics IPO and Vahh Chemicals IPO is , and , respectively.
Genxai Analytics IPO P/E ratio is , as compared to Vahh Chemicals IPO P/E ratio of .
| Genxai Analytics IPO | Vahh Chemicals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Genxai Analytics Ltd.'s revenue increased by 19% and profit after tax (PAT) rose by 147% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 90.28 | 88.52 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 64.63 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 65.40 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 70.26 | 25.72 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.66 | 1.64 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 85.49 | 38.52 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Genxai Analytics IPO Retail Individual Investors (RII) are offered 0 shares while in Vahh Chemicals IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Genxai Analytics IPO and 0 shares in Vahh Chemicals IPO.
| Genxai Analytics IPO | Vahh Chemicals IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 1,14,000 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 10,64,000 shares |
| RII | 0 shares | 10,64,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 21,28,000 shares |
Genxai Analytics IPO subscribed in total, whereas Vahh Chemicals IPO subscribed .
